163 related articles for article (PubMed ID: 23329398)
1. A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job.
Chen SL; Zheng MH; Shi KQ; Yang T; Chen YP
BioDrugs; 2013 Feb; 27(1):25-34. PubMed ID: 23329398
[TBL] [Abstract][Full Text] [Related]
2. Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential.
Kong D; Zhang F; Zhang Z; Lu Y; Zheng S
Biomed Pharmacother; 2013 Apr; 67(3):246-50. PubMed ID: 23201010
[TBL] [Abstract][Full Text] [Related]
3. Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate Cells.
Coll M; El Taghdouini A; Perea L; Mannaerts I; Vila-Casadesús M; Blaya D; Rodrigo-Torres D; Affò S; Morales-Ibanez O; Graupera I; Lozano JJ; Najimi M; Sokal E; Lambrecht J; Ginès P; van Grunsven LA; Sancho-Bru P
Sci Rep; 2015 Jun; 5():11549. PubMed ID: 26096707
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
6. The potential of microRNAs in liver fibrosis.
He Y; Huang C; Zhang SP; Sun X; Long XR; Li J
Cell Signal; 2012 Dec; 24(12):2268-72. PubMed ID: 22884954
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling.
Hyun J; Jung Y
World J Gastroenterol; 2016 Aug; 22(29):6652-62. PubMed ID: 27547008
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNAs in Hepatic Stellate Cells and Hepatic Fibrosis: An Update.
Zhu S; Chen X; Chen Y; Li XF; Chen SY; Li JJ; Wang A; Huang C; Li J
Curr Pharm Des; 2021; 27(27):3000-3011. PubMed ID: 33100194
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
Ogawa T; Enomoto M; Fujii H; Sekiya Y; Yoshizato K; Ikeda K; Kawada N
Gut; 2012 Nov; 61(11):1600-9. PubMed ID: 22267590
[TBL] [Abstract][Full Text] [Related]
10. lincRNA-p21 inhibits hepatic stellate cell activation and liver fibrogenesis via p21.
Zheng J; Dong P; Mao Y; Chen S; Wu X; Li G; Lu Z; Yu F
FEBS J; 2015 Dec; 282(24):4810-21. PubMed ID: 26433205
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA function in the profibrogenic interplay upon chronic liver disease.
Huang J; Yu X; Fries JW; Zhang L; Odenthal M
Int J Mol Sci; 2014 May; 15(6):9360-71. PubMed ID: 24871365
[TBL] [Abstract][Full Text] [Related]
13. New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery.
Bian EB; Zhao B; Huang C; Wang H; Meng XM; Wu BM; Ma TT; Zhang L; Lv XW; Li J
Cell Signal; 2013 Sep; 25(9):1837-44. PubMed ID: 23707524
[TBL] [Abstract][Full Text] [Related]
14. Suppression of collagen synthesis by Dicer gene silencing in hepatic stellate cells.
Yu F; Lin Z; Zheng J; Gao S; Lu Z; Dong P
Mol Med Rep; 2014 Feb; 9(2):707-14. PubMed ID: 24337369
[TBL] [Abstract][Full Text] [Related]
15. Research Progress on the Effect of Autophagy and Exosomes on Liver Fibrosis.
Du Y; Zhu S; Zeng H; Wang Z; Huang Y; Zhou Y; Zhang W; Zhu J; Yang C
Curr Stem Cell Res Ther; 2024; 19(6):785-797. PubMed ID: 37102476
[TBL] [Abstract][Full Text] [Related]
16. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway.
Dai W; Zhao J; Tang N; Zeng X; Wu K; Ye C; Shi J; Lu C; Ning B; Zhang J; Lin Y
Liver Int; 2015 Apr; 35(4):1234-43. PubMed ID: 25142507
[TBL] [Abstract][Full Text] [Related]
18. PTP1B confers liver fibrosis by regulating the activation of hepatic stellate cells.
Chen PJ; Cai SP; Yang Y; Li WX; Huang C; Meng XM; Li J
Toxicol Appl Pharmacol; 2016 Feb; 292():8-18. PubMed ID: 26739621
[TBL] [Abstract][Full Text] [Related]
19. Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH.
Wang Y; Liu Z; Zou W; Hong H; Fang H; Tong W
Biomark Med; 2015; 9(11):1189-200. PubMed ID: 26506944
[TBL] [Abstract][Full Text] [Related]
20. microRNA-34a and microRNA-34c promote the activation of human hepatic stellate cells by targeting peroxisome proliferator-activated receptor γ.
Li X; Chen Y; Wu S; He J; Lou L; Ye W; Wang J
Mol Med Rep; 2015 Feb; 11(2):1017-24. PubMed ID: 25370690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
